LeMaitre Vascular to Present at Upcoming Investor Conferences
Rhea-AI Summary
LeMaitre Vascular (Nasdaq:LMAT) announced its participation in two investor conferences this November. David Roberts, President, will present at the Stifel Virtual Healthcare Conference on November 16, 2020, at 8:00 AM ET. Meanwhile, JJ Pellegrino, Chief Financial Officer, is set to speak at the Canaccord Genuity 2020 Medical Technologies & Diagnostics Forum on November 19, 2020, at 9:30 AM ET. LeMaitre Vascular specializes in devices for treating peripheral vascular disease, serving over 200 million people globally.
Positive
- None.
Negative
- None.
News Market Reaction – LMAT
In the trading session that priced this news, LMAT declined 1.32%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in November.
David Roberts, President, is scheduled to present at the Stifel Virtual Healthcare Conference on Monday, November 16, 2020, at 8:00 AM ET.
JJ Pellegrino, Chief Financial Officer, is scheduled to present at the Canaccord Genuity 2020 Medical Technologies & Diagnostics Forum on Thursday, November 19, 2020, at 9:30 AM ET.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.